The new system, now approved by the FDA, uses robotics and software algorithms to speed up the testing process and can provide six to eight hours of uninterrupted processing — which would normally require multiple lab technician interactions.
The BD COR System will initially be available with the BD Onclarity HPV Assay and can be used by the high-throughput labs that process most cervical cancer screening specimens in the U.S.
